b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">29296755</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Print">2473-9529</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>1</Volume>\n                    <Issue>15</Issue>\n                    <PubDate>\n                        <Year>2017</Year>\n                        <Month>Jun</Month>\n                        <Day>27</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Blood advances</Title>\n                <ISOAbbreviation>Blood Adv</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>12-HETrE inhibits platelet reactivity and thrombosis in part through the prostacyclin receptor.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1124-1131</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1182/bloodadvances.2017006155</ELocationID>\n            <Abstract>\n                <AbstractText>The dihomo-\xce\xb3-linolenic acid (DGLA)-derived metabolite of 12-lipoxygenase, 12-hydroxy-eicosatrienoic acid (12-HETrE), was recently shown to potently inhibit thrombus formation without prolonging bleeding in murine models. Although 12-HETrE was found to inhibit platelet activation via the G\xce\xb1<sub>s</sub> signaling pathway, the G\xce\xb1<sub>s</sub>-coupled receptor by which 12-HETrE mediates its antiplatelet effects has yet to be identified. Defining the receptor by which 12-HETrE exerts its effects is key to determining its therapeutic potential as an antiplatelet drug. Therefore, the goal of this study was to determine the G\xce\xb1<sub>s</sub>-coupled platelet receptor through which 12-HETrE exerts its antiplatelet effects. In this study, we showed that pharmacological inhibition of the prostacyclin (IP) receptor in human platelets or genetic ablation of IP in murine platelets prevented 12-HETrE from blocking aggregation in vitro. Furthermore, the antithrombotic effects of 12-HETrE were significantly diminished in IP knockout mice in vivo. Together these data demonstrate that the antiplatelet effects of 12-HETrE are at least partially dependent on IP signaling. Importantly, this work identified 12-HETrE as a novel regulator of IP signaling that may aid in the rationale for design of novel therapeutics to inhibit platelet function. Additionally, this study provides further insight into the mechanism by which DGLA supplementation inhibits platelets function.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Tourdot</LastName>\n                    <ForeName>Benjamin E</ForeName>\n                    <Initials>BE</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, University of Michigan, Ann Arbor, MI.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Adili</LastName>\n                    <ForeName>Reheman</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, University of Michigan, Ann Arbor, MI.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Isingizwe</LastName>\n                    <ForeName>Zitha R</ForeName>\n                    <Initials>ZR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, University of Michigan, Ann Arbor, MI.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ebrahem</LastName>\n                    <ForeName>Meral</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, University of Michigan, Ann Arbor, MI.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Freedman</LastName>\n                    <ForeName>J Cody</ForeName>\n                    <Initials>JC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA; and.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Holman</LastName>\n                    <ForeName>Theodore R</ForeName>\n                    <Initials>TR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA; and.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Holinstat</LastName>\n                    <ForeName>Michael</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacology, University of Michigan, Ann Arbor, MI.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>R01 GM105671</GrantID>\n                    <Acronym>GM</Acronym>\n                    <Agency>NIGMS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>R01 MD007880</GrantID>\n                    <Acronym>MD</Acronym>\n                    <Agency>NIMHD NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>F32 HL129491</GrantID>\n                    <Acronym>HL</Acronym>\n                    <Agency>NHLBI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>R01 AG047986</GrantID>\n                    <Acronym>AG</Acronym>\n                    <Agency>NIA NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>R01 HL114405</GrantID>\n                    <Acronym>HL</Acronym>\n                    <Agency>NHLBI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>06</Month>\n                <Day>23</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Blood Adv</MedlineTA>\n            <NlmUniqueID>101698425</NlmUniqueID>\n            <ISSNLinking>2473-9529</ISSNLinking>\n        </MedlineJournalInfo>\n        <CoiStatement>Conflict-of-interest disclosure: The authors declare no competing financial interests.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>02</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>05</Month>\n                <Day>25</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29296755</ArticleId>\n            <ArticleId IdType="doi">10.1182/bloodadvances.2017006155</ArticleId>\n            <ArticleId IdType="pii">2017/006155</ArticleId>\n            <ArticleId IdType="pmc">PMC5728320</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Blood. 2009 Feb 19;113(8):1809-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19036705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Med. 2013 Dec;19(12):1609-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24216752</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arterioscler Thromb Vasc Biol. 2016 Oct;36(10 ):2068-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27470510</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurosci. 2002 Jan 1;22(1):257-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11756509</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hematol Oncol Clin North Am. 2007 Aug;21(4):633-45, v-vi</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17666282</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2014 Oct 5;740:15-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25003953</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Lipid Res. 2012 Dec;53(12):2546-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22984144</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2005 Oct 15;106(8):2723-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15972447</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2644-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25278289</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2016 Jul 26;115(3):364-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27362730</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 1997 Aug 14;388(6643):678-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9262402</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2011 Sep 30;286(39):33832-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21712392</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'